keyboard and monitors

Last week’s round-up, 28 October 2019 – 01 November 2019

By Tessa Fiorini-Cohen and Marthese Mifsud   OGD Explains How it Reviews and Conducts Pre-ANDA Meetings 01 November 2019 The FDA’s Office of Generic Drugs (OGD) has explained how it evaluates and conducts meetings under its pre-abbreviated new drug application (ANDA) program. To this end, the OGD has issued a manual of policies and procedures, […]

Read More